Chinese Clinical Oncology

CD30+ T-cell lymphoproliferative disorders.

Sézary Syndrome, recent biomarkers and new drugs.

Epidemiology of gallbladder cancer in India.

Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?

Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report.

Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature.

Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.

Renal ablation: current management strategies and controversies.

Management of gallbladder cancer in India.

The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.

Pembrolizumab plus axitinib: a new treatment option for patients with metastatic renal cell carcinoma.

Adjuvant therapy for resected gallbladder cancer.

Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy.

Gallbladder cancer: surgical management.

Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome.

Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).

New technological advancements for interventional oncology.

Interactions of multiple gene alterations in colorectal liver metastases.

Limitations of molecular biomarkers in patients with resectable colorectal liver metastases.

Role of image-guided biopsy and radiomics in the age of precision medicine.

Breast cancer prognostic staging and internal mammary lymph node metastases: a brief overview.

Staging systems and nomograms in soft tissue sarcoma: outcome prediction by categorization or personalization?

The value of sonographically guided fine-needle aspiration in the diagnosis of small lymph.

Percutaneous palliative care interventions in the cancer patient.

Emerging insights on the biology and treatment of cutaneous T-cell lymphoma.

Population diversity in oncology drug responses and implications to drug development.

Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.

Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer

Interventional oncology: aiming globally to be the 4th pillar of cancer care.

The dawn of a universal language for an emerging malignancy.

Is it time for a specific score for venous thromboembolism risk assessment for non-solid tumors?

A closer look at the staging of soft tissue sarcomas in an era of personalized medicine.

The state of hepatic artery infusion chemotherapy in the management of metastatic colorectal cancer to the liver.

Incidental high-grade dysplasia of the cystic duct margin: case report and literature review.

Gentle skin care guidelines for patients with mycosis fungoides.

Advances in percutaneous lung tumor therapy: 2019 update.

Immune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy.

Gallbladder cancer, a forgotten global cancer problem.

Bendamustine plus rituximab: is it a BRIGHT idea?

AJCC 8th edition staging system for pathologically versus clinically staged intrahepatic cholangiocarcinoma (iCCA): ready for prime time?

A narrative review of tropisetron and palonosetron for the control of chemotherapy-induced nausea and vomiting.

Applications of transcatheter embolotherapy in preparation for liver transplantation and resection.

A step ahead on CTHRC1, and not just reinventing the wheel!

The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides.

Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea.

Embolotherapy of unresectable hepatocellular carcinoma: Eastern perspective.

Perioperative safety in patients with resectable synchronous colorectal liver metastases.